Researchers: Trigeminal neuralgia options inadequate | Intervention helps give cancer patients power over pain | Opioid use before knee replacement tied to more postsurgical pain
May 24, 2017
News for the pain professional
SIGN UP ⋅   FORWARD
Pain Research News
ADVERTISEMENT
Researchers: Trigeminal neuralgia options inadequate
There is a high burden of illness associated with trigeminal neuralgia and current treatments do not fully meet patient needs, researchers told the American Pain Society's annual meeting. Carbamazepine is the only FDA-approved drug for trigeminal neuralgia, but other medications are used off-label to reduce the orofacial pain.
Neurology Advisor (5/24) 
LinkedIn Twitter Facebook Google+ Email
Intervention helps give cancer patients power over pain
The Power Over Pain -- Coaching pain management intervention, created to give patients the perception they have control over pain, was found to improve pain measures among African-Americans with cancer, compared with a control group, according to a study reported at the American Pain Society's annual meeting. The POP-C program includes medication management, pain advocacy and aspects of living with pain.
Medscape (free registration) (5/23) 
LinkedIn Twitter Facebook Google+ Email
Other News
Treatment News
Transcranial stimulation reduces knee pain severity in trial
The use of transcranial direct-current stimulation to treat knee osteoarthritis resulted in greater reductions in knee pain severity than a sham treatment, researchers told the American Pain Society's annual meeting. Researcher Brian Ahn of the University of Texas Health Center suggested the neuromodulatory effects of tDCS may be the mechanism for pain relief.
Medscape (free registration) (5/22) 
LinkedIn Twitter Facebook Google+ Email
Study: Polyneuropathy patients at risk with long-term opioids
A population-based study in JAMA Neurology linked long-term opioid use among polyneuropathy patients to an increased risk of adverse events without improved function. Patients taking opioids for at least 90 days were more likely to rely on gait aids, have trouble climbing stairs, have depression, and experience opioid dependence and overdose, compared with patients in a control group.
MedPage Today (free registration) (5/23) 
LinkedIn Twitter Facebook Google+ Email
Other News
Policy & Trends
Surgery patients often have leftover opioids, study finds
Researchers told the American Pain Society's annual meeting that up to 85% of orthopedic surgery patients who completed opioid therapy after their procedures had unused medication, with an average of 30 leftover pills. Researchers said data from other surgical specialties showed similar results.
Medscape (free registration) (5/22) 
LinkedIn Twitter Facebook Google+ Email
Opioid prescription rates for minor injuries vary by state
A study presented at the Society for Academic Emergency Medicine's annual meeting showed significant variation in opioid prescribing patterns for patients with minor injuries who were seen at hospital emergency departments. Overall, only 7% of patients got an opioid prescription in the ED, but the rates varied from 1.6% in Delaware to 16% in Mississippi.
Physician's Briefing/HealthDay News (5/22) 
LinkedIn Twitter Facebook Google+ Email
Other News
APS News
2018 call for symposia
The APS Scientific Program Committee (SPC) invites the submission of proposals for Focused Symposia for the 2018 Scientific Summit. Topics should align with the theme of understanding pain mechanisms and pain treatment mechanisms. Deadline to submit research is June 12, 2017. Learn more.
LinkedIn Twitter Facebook Google+ Email
Obtain your continuing education credit
Certificates of continuing education credit are available upon completion. Access online evaluations.
LinkedIn Twitter Facebook Google+ Email
  
  
Restlessness is discontent -- and discontent is the first necessity of progress.
Thomas Edison,
inventor
LinkedIn Twitter Facebook Google+ Email
  
  
Learn more about APS:
Membership | Annual Meeting | Education
Funding Opportunities | About Us
Sign Up
SmartBrief offers 200+ newsletters
Advertise
Learn more about the SmartBrief audience
Subscriber Tools:
Contact Us:
Advertising  -  Wynn Hansen
P: 202.470.1149
Partner Relations Manager  -  Lauren Barr
Editor  -  Tom Parks
Mailing Address:
SmartBrief, Inc.®, 555 11th ST NW, Suite 600, Washington, DC 20004
© 1999-2017 SmartBrief, Inc.®
Privacy policy |  Legal Information